Hepatitis Weekly
Susan Hasty, Publisher
Table of Contents . . . February 16th, 2004
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Hepatitis Weekly | Other Publications
Chronic Hepatitis B - Early treatment response foreshadows good outcomes for patients with HBV type C
Gastroenterology - Interferon lowers the risk for liver cancer in patients with chronic hepatitis C
Hemophilia - Treatment for HIV and HCV infections in hemophiliacs reviewed
Hepatitis A Vaccine - Typhoid/hepatitis A vaccine effective as booster dose in primed adults
Hepatitis B Vaccine - HBsAg variants break tolerance in hepatitis B surface antigen mice
Hepatitis C Virus - Chronic hepatitis C patients to benefit from guidance on new drugs and treatments
Hepatitis C Virus - FIBOSpect II introduced for detection of liver fibrosis
Hepatitis C Virus - Rebetol Oral Solution available for treating pediatric hepatitis C
Hepatitis Testing - Company completes independent test for hepatitis B in China
Hepatocellular Cancer - Radiofrequency ablation and transcatheter chemoembolization are used for HCC
Hepatoma - Geranylgeranylation blockade is a new strategy for treating hepatitis C virus
Oncology - Four heat shock proteins are biomarkers for HCV-related liver cancer
Immunology - Intrahepatic CD8 T-lymphocyte levels mark chronic hepatitis B treatment response
Immunology - Neutrophils govern T-cell recruitment and hepatitis formation
Infection - Quantitative analyses illuminate ribavirin and HCV RNA polymerase binding
Liver Cancer - Those treated for HCV-related cancer have better odds if inflammation declines
Liver Fibrosis - Exploratory phase II study: Gamma-1b is generally well tolerated
Metastasis - Loss of TIP30 heightens susceptibility to tumor development
Personnel - Jennifer Giottonini named VP, corporate development
Personnel - Michael Markels to lead sales and marketing for neuropathic pain company
Virology - Hepatitis C virus subgenomic replicons can be grown in nonhepatic cells
Gastroenterology - Transgenic mice offer a new way to study hepatitis C virus immunopathology
Hepatitis C Virus - Viral kinetics elucidate therapeutic response in chronic hepatitis C patients
Oncogenesis - Patients with hepatitis B and C coinfections have a slightly higher cancer rate
Viral Genomics - Hepatitis B virus DNA integration occurs early during acute infection
Cancer Therapy - Gamma-linolenic acid infusion occludes vessels that feed tumors
Cell Biology - Antibody from liver disease patients slows oxidative muscle cell respiration
Enzymology - Hepatitis C virus core protein upregulates enzyme inhibitor to stop apoptosis
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
